LLY and NVO have been hit hard over the last couple weeks over news of potential competition from other pharma companies for weight loss drugs. But I feel like the sell off has been largely an overreaction since the competition is still several years at best from getting their drugs to market. They're only at phase 2 drug trials.
But anyways, do people think LLY and NVO are good buys right now especially since they are about to release their earnings in early Aug?
Leave a Reply